Table 5 Average number of months spent retained on buprenorphine above the retention thresholds overall and by the presence of cocaine or hazardous alcohol use at initiation restricted to 2 years after initiating buprenorphine treatment among participants with HIV and opioid use disorder in the Johns Hopkins HIV Clinical Cohort, 2013-2020

6.4 (4.1, 8.9)

4.1 (3.0, 5.2)

2.3 (1.2, 3.8)

1.8 (0.1, 3.5)

3.7 (2.7, 4.8)

2.8 (1.3, 4.5)

0.9 (–1.0, 2.8)

7.5 (5.1, 10.2)

5.0 (3.8, 6.3)

2.5 (1.3, 3.9)

2.5 (0.6, 4.2)

4.5 (3.4, 5.7)

3.1 (1.6, 4.9)

1.4 (–0.6, 3.4)

9.0 (6.2, 12.1)

5.7 (4.4, 7.1)

3.3 (1.8, 5.0)

2.4 (0.4, 4.4)

5.2 (4.0, 6.5)

4.0 (2.1, 6.0)

1.2 (–1.1, 3.5)

10.4 (7.5, 13.7)

6.8 (5.4, 8.4)

3.6 (2.1, 5.3)

3.2(1.1, 5.3)

6.1 (4.9, 7.5)

4.4 (2.5, 6.6)

1.7 (–0.7, 4.1)